Systemic Inflammatory Response Index (SIRI) at Baseline Predicts Clinical Response for a Subset of Treatment-Resistant Bipolar Depressed Patients

Background: in a recent double-blind, placebo controlled RCT we demonstrated that selective inhibition of cyclo-oxygenase 2 (COX2) is an effective adjunctive strategy in treatment-resistant bipolar depression (TRBDD). To better clarify the mechanisms underlying TRBDD and treatment response, we condu...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Stephen, Baig, Nausheen, Decker, Kyle, Halaris, Angelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533150/
https://www.ncbi.nlm.nih.gov/pubmed/37763175
http://dx.doi.org/10.3390/jpm13091408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533150/
https://www.ncbi.nlm.nih.gov/pubmed/37763175
http://dx.doi.org/10.3390/jpm13091408

Ejemplares similares